Fansimef

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Definition
This section has been translated automatically.

Antimalaria drug not approved in Germany, combination preparation of mefloquine (250 mg), sulfadoxine (500 mg) and pyrimethamine (25 mg) per tbl.

Half-life
This section has been translated automatically.

4–16 h

Indication
This section has been translated automatically.

Chloroquine-resistant malaria through Pl. falciparum.

Dosage and method of use
This section has been translated automatically.

  • Non-immune adults and adults with > 60 kg bw: 3 tbl/day.
  • Adults < 60 kg KG and children 10-14 years (31-45 kg): 2 tbl/day
  • children 7-9 years (21-30 kg): 1 1/2 dbl/day
  • children 4-6 years (11-20 kg): 1 dbl./day
  • children < 4 years (5-10 kg): 1/2 dbl/day

Undesirable effects
This section has been translated automatically.

Interactions
This section has been translated automatically.

Contraindication
This section has been translated automatically.

Hypersensitivity to one of the ingredients, blood formation disorders, epilepsy, newborns.

Authors

Last updated on: 29.10.2020